234 related articles for article (PubMed ID: 25810396)
1. The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival.
Ainsua-Enrich E; Serrano-Candelas E; Álvarez-Errico D; Picado C; Sayós J; Rivera J; Martín M
J Immunol; 2015 May; 194(9):4309-18. PubMed ID: 25810396
[TBL] [Abstract][Full Text] [Related]
2. Myo1f, an Unconventional Long-Tailed Myosin, Is a New Partner for the Adaptor 3BP2 Involved in Mast Cell Migration.
Navinés-Ferrer A; Ainsua-Enrich E; Serrano-Candelas E; Sayós J; Martin M
Front Immunol; 2019; 10():1058. PubMed ID: 31143189
[TBL] [Abstract][Full Text] [Related]
3. MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation.
Proaño-Pérez E; Ollé L; Guo Y; Aparicio C; Guerrero M; Muñoz-Cano R; Martin M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834926
[TBL] [Abstract][Full Text] [Related]
4. The adaptor 3BP2 is required for early and late events in FcεRI signaling in human mast cells.
Ainsua-Enrich E; Alvarez-Errico D; Gilfillan AM; Picado C; Sayós J; Rivera J; Martín M
J Immunol; 2012 Sep; 189(6):2727-34. PubMed ID: 22896635
[TBL] [Abstract][Full Text] [Related]
5. KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.
Lee YN; Brandal S; Noel P; Wentzel E; Mendell JT; McDevitt MA; Kapur R; Carter M; Metcalfe DD; Takemoto CM
Blood; 2011 Mar; 117(13):3629-40. PubMed ID: 21273305
[TBL] [Abstract][Full Text] [Related]
6. Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.
Serrano-Candelas E; Ainsua-Enrich E; Navinés-Ferrer A; Rodrigues P; García-Valverde A; Bazzocco S; Macaya I; Arribas J; Serrano C; Sayós J; Arango D; Martin M
Mol Oncol; 2018 Aug; 12(8):1383-1397. PubMed ID: 29885053
[TBL] [Abstract][Full Text] [Related]
7. Association of 3BP2 with SHP-1 regulates SHP-1-mediated production of TNF-α in RBL-2H3 cells.
Chihara K; Nakashima K; Takeuchi K; Sada K
Genes Cells; 2011 Dec; 16(12):1133-45. PubMed ID: 22077594
[TBL] [Abstract][Full Text] [Related]
8. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
Miah SM; Hatani T; Qu X; Yamamura H; Sada K
Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation.
Westerberg CM; Hägglund H; Nilsson G
Cell Death Dis; 2012 Nov; 3(11):e417. PubMed ID: 23152053
[TBL] [Abstract][Full Text] [Related]
10. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
11. Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice.
Tsujimura T; Morii E; Nozaki M; Hashimoto K; Moriyama Y; Takebayashi K; Kondo T; Kanakura Y; Kitamura Y
Blood; 1996 Aug; 88(4):1225-33. PubMed ID: 8695840
[TBL] [Abstract][Full Text] [Related]
12. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.
Sundström M; Vliagoftis H; Karlberg P; Butterfield JH; Nilsson K; Metcalfe DD; Nilsson G
Immunology; 2003 Jan; 108(1):89-97. PubMed ID: 12519307
[TBL] [Abstract][Full Text] [Related]
13. Adaptor protein 3BP2 and cherubism.
Hatani T; Sada K
Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
[TBL] [Abstract][Full Text] [Related]
14. The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth.
Proaño-Pérez E; Serrano-Candelas E; García-Valverde A; Rosell J; Gómez-Peregrina D; Navinés-Ferrer A; Guerrero M; Serrano C; Martín M
Cancer Gene Ther; 2023 Feb; 30(2):245-255. PubMed ID: 36241703
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Bandara G; Falduto GH; Luker A; Bai Y; Pfeiffer A; Lack J; Metcalfe DD; Olivera A
Front Immunol; 2023; 14():1078958. PubMed ID: 37025992
[TBL] [Abstract][Full Text] [Related]
16. IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3.
Desai A; Jung MY; Olivera A; Gilfillan AM; Prussin C; Kirshenbaum AS; Beaven MA; Metcalfe DD
J Allergy Clin Immunol; 2016 Jun; 137(6):1863-1871.e6. PubMed ID: 26774658
[TBL] [Abstract][Full Text] [Related]
17. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
19. The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells.
Yamazaki S; Nakano N; Honjo A; Hara M; Maeda K; Nishiyama C; Kitaura J; Ohtsuka Y; Okumura K; Ogawa H; Shimizu T
J Immunol; 2015 Oct; 195(7):3427-35. PubMed ID: 26297757
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
